Anthropic and OpenAI release cheaper models as price war intensifies - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号)。如果该手机号尚未注册,将自动创建 FT中文网账号。短信可能需要几分钟送达,验证码15分钟内有效,请耐心等待:
请您阅读我们的用户注册协议和隐私权保护政策,点击下方按钮即视为您接受。
人工智能

Anthropic and OpenAI release cheaper models as price war intensifies

New Claude and ChatGPT tools slash costs from earlier versions while promising better performance
00:00

{"text":[[{"start":9.16,"text":"Anthropic and OpenAI both released cheaper versions of their leading models on Tuesday, as the price war between the two leading US labs and their low-cost Chinese rivals intensifies."}],[{"start":21.08,"text":"The latest Claude model from Anthropic, Opus 5.5, is roughly 40 per cent cheaper to use than its precursor and was the first of a new “family” of models that will be more cost-efficient than previous generations, the company said."}],[{"start":35.08,"text":"OpenAI, meanwhile, released lower-cost versions of ChatGPT-6, known as Sol and Luna, following the release of its most advanced ChatGPT-6 Astra model at the start of the month. It said the models will be 50 per cent cheaper than their predecessors in the ChatGPT-5.6 slate."}],[{"start":54.16,"text":"The rival US AI labs are increasingly competing on both price and performance for cost-conscious business customers, after a period characterised by an all-out race for the highest capabilities."}],[{"start":67.04,"text":"Anthropic is aiming to bolster its customer base ahead of a planned IPO this autumn that is expected to be the largest of all time. Investors have speculated that a new model release would be the catalyst for the company to release its long-awaited IPO prospectus."}],[{"start":82.36,"text":"They are closely watching for signs that the group can sustain its blistering growth rate in the coming years amid intensifying competition and increasingly price-sensitive customers."}],[{"start":92.44,"text":"OpenAI has said it is unlikely to go public before 2027. It has slashed the prices of its models in recent months, seeking to kick-start its growth after a sluggish start to the year. The company also claims its Astra model is the most powerful model on the market."}],[{"start":109.28,"text":"Anthropic’s Opus 5.5 will cost $4 per million input tokens and $20 per million output tokens. Tokens are the units of data that comprise AI queries. Opus would be able to perform most tasks at the same level as the group’s most powerful tool, Fable 5.1, the company said."}],[{"start":128.68,"text":"Fable 5.1 is priced at $10 per million input tokens and $50 per million output tokens, the same as OpenAI’s Astra."}],[{"start":135.72,"text":"Its next-most-powerful Sol model costs $2 per million input tokens and $10 per million output tokens, while the lightweight Luna version costs $0.10 per million input tokens and $0.50 per million output tokens."}],[{"start":148.52,"text":"Both Anthropic and OpenAI are facing renewed threats from “open-weight” models, which users can customise and run on their own hardware. These models, mostly from China, are taking share from US labs, according to data from cloud application company Vercel."}],[{"start":162.44,"text":"Opus 5.5 is the first model released by the company since its chief executive Dario Amodei called on AI labs to “pace the frontier” of development and more deeply embed third-party testers, in an effort to mitigate AI risks and security breaches after researchers warned that the unchecked race to build self-improving superintelligence could destroy humanity."}],[{"start":183.76,"text":"Anthropic said its new model had undergone “extensive alignment testing, pre-release evaluation by outside organisations, and [included] safeguards for high-risk areas like cyber security and biology”."}],[{"start":194.36,"text":"OpenAI on Tuesday set its priorities for further work with independent evaluators — including training, safeguards, preparedness and investigating incidents — after Anthropic last week said it would work with Accenture on safety testing."}],[{"start":212.4,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1790122710_6488.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

英伟达董事会的虚假独立性

治理话题令人犯困。

中国科技股大幅回落,投资AI或许少些波折

中国的机遇同样蕴藏在AI供应链的“卖铲人”环节。

英伟达的个人崇拜注定不会善终

值得留意企业傲慢自大的警讯——这往往意味着坏事即将发生。

无根之人最终赢了

人们或许不会投票支持自由个人主义,但他们践行着它。

耗资5亿美元的罗摩衍那押注全球成功

宝莱坞史上成本最高的电影更看重CGI视觉奇观,而非精神震撼——但要收回成本,或许还得靠奇迹。

我们很快就能治愈癌症吗?

近期,药物预防和治疗领域的革命性进展让科学家距离战胜这些最令人恐惧的疾病仅一步之遥,但棘手的挑战依然存在。
设置字号×
最小
较小
默认
较大
最大
分享×